Literature DB >> 10363719

The antigen binding domain of non-idiotypic human anti-F(ab')2 autoantibodies: study of their interaction with IgG hinge region epitopes.

M Welschof1, U Reineke, C Kleist, S Kipriyanov, M Little, R Volkmer-Engert, J Schneider-Mergener, G Opelz, P Terness.   

Abstract

In previous studies we described a natural human IgG-anti-F(ab')2 autoantibody family with immunoregulatory properties. Genes coding for the variable regions of the heavy and light chains of the Abs were isolated from a natural Ig gene library and scFv Abs were expressed in E. coli. The scFv Abs bound to F(ab')2 but not to Fab fragments. This points to an epitope located in the hinge region since Fab fragments are lacking most of the hinge. In order to verify our hypothesis, double chain peptides comprising the lower-, middle-, and part of the upper hinge subregion of IgG1-IgG4 were synthesized on cellulose membranes and tested for binding to the Abs. The results show binding of Abs to IgG1 and IgG4 hinge region peptides. In order to identify the key residues of the discontinuous epitopes we carried out complete substitutional analyses in which each amino acid of the wt peptides was substituted by all other amino acids except cysteine. The exchange of proline in the IgG1 or IgG4 middle hinge region abrogated the binding, revealing the importance of this subregion for epitope expression. No binding to the IgG2 or IgG3 hinge was detected. These results indicate that scFv anti-F(ab')2 Abs recognize the hinge region of IgG1 and IgG4 and that the expression of the epitope depends on an intact middle hinge subregion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363719     DOI: 10.1016/s0198-8859(98)00132-3

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

Review 1.  Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Authors:  Leendert A Trouw; Theo Rispens; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

2.  Autoantibodies to variable heavy (VH) chain Ig sequences in humans impact the safety and clinical pharmacology of a VH domain antibody antagonist of TNF-α receptor 1.

Authors:  M C Holland; J U Wurthner; P J Morley; M A Birchler; J Lambert; M Albayaty; A P Serone; R Wilson; Y Chen; R M Forrest; J C Cordy; D A Lipson; A I Bayliffe
Journal:  J Clin Immunol       Date:  2013-07-06       Impact factor: 8.317

Review 3.  Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology.

Authors:  Yanchen Zhou; Hweixian L Penny; Mark A Kroenke; Bianca Bautista; Kelly Hainline; Lynette S Chea; Jane Parnes; Daniel T Mytych
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 12.469

4.  IgG anti-hinge antibodies against IgG4 F(ab')2 fragments generated using pepsin are useful diagnostic markers for rheumatoid arthritis: implications of the possible roles of metalloproteinases and IgG subclasses in generating immunogenic hinge epitopes.

Authors:  Toshiyuki Ota; Shun-Ichiro Ota; Ayumi Uchino; Shuji Nagano
Journal:  Arthritis Res Ther       Date:  2020-06-26       Impact factor: 5.156

5.  Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression.

Authors:  Lingyu Kong; Zhongbing Wu; Yang Zhao; Xin Lu; Huijuan Shi; Shugang Liu; Jing Li
Journal:  Biosci Rep       Date:  2019-06-04       Impact factor: 3.840

Review 6.  Proteinase-nicked IgGs: an unanticipated target for tumor immunotherapy.

Authors:  Robert E Jordan; Xuejun Fan; Georgina Salazar; Ningyan Zhang; Zhiqiang An
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.